Projectes

IrsiCaixa compta amb un centenar de projectes de recerca nacionals i internacionals actius cada any, finançats tant per entitats públiques com privades.

Paraules clau

Grup de recerca

Investigador/a

Des del

Fins el

Enhancing Tissue-Specific Immune Microenvironments for the Cure of HIV. ETI-CURE “La Caixa” Health Research HR20-00218

Estatus del projecte

Vigent

Inici/Fi

2021

/

2024

Investigador/a principal

Julia García Prado

Personal investigador extern

Maria José Buzón

Entitats participants

Irsicaixa / VHIR / Universidad Autónoma de Madrid

Entitat finançadora

ETI-CURE “La Caixa” Health Research
DURVAST: A phase II exploratory study of durvalumab (MEDI4736) in HIV-1 patients with advanced solid tumors

Estatus del projecte

Vigent

Inici/Fi

2017

/

2019

Investigador/a principal

Javier Martínez-Picado

Entitats participants

Spanish Lung Cancer Cooperative Group & IrsiCaixa AIDS Research Institute.

Entitat finançadora

AstraZeneca
Translational study of Inhibitory Receptors in HIV-1 infection: Identification of novel immunotherapeutic targets to reverse T-cell immune exhaustion

Estatus del projecte

Vigent

Inici/Fi

2018

/

2020

Investigador/a principal

Julia García Prado

Entitats participants

Institut de Recerca de la Sida IrsiCaixa

Entitat finançadora

Ministry of the Economy, Industry and Competitiveness - Carlos III Health Institute (ISCIII) – FEDER. PI17/00164
Preclinical evaluation of immunoregulatory molecules in combination with latency reactivators for the development of new HIV-1 erradication strategies

Estatus del projecte

Vigent

Inici/Fi

2015

/

2018

Investigador/a principal

Julia García Prado

Entitat finançadora

Ministry of the Economy and Competitiveness - Carlos III Health Institute (ISCIII) - FEDER. PI14/01058